Barriers to insulin injection therapy: patient and health care provider perspectives

The Diabetes Educator
Richard R RubinLuther B Travis

Abstract

To compare patients' perceptions of injection-related problems with clinicians' estimates of those problems. Data were obtained through 2 Internet surveys, one of US adults self-identified as taking insulin to treat diabetes and the second of health care professionals who treat people with diabetes who inject insulin, including primary care physicians, endocrinologists, and diabetes educators. A substantial majority of patients would like to reduce the number of injections they take each day; almost half said that they would be more likely to take their insulin injections regularly if a product were available to ease the pain. A much smaller proportion of patients reported that (1) injections were a serious burden, (2) they were dissatisfied with the way they took insulin, (3) injections had a substantial negative impact on quality of life, (4) they skipped injections they should take, or (5) injection-related problems affected the number of injections they were willing to take. Half of the patients said they mentioned injection-related problems to their provider; a similar number reported that their providers had not given them a solution to problems with injection-related pain and bruising. Although awareness of products to e...Continue Reading

References

Nov 26, 1997·Diabetic Medicine : a Journal of the British Diabetic Association·F J SnoekH M van der Ploeg
Sep 24, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·M PeyrotS E Skovlund
Sep 28, 2005·Diabetes Care·William H PolonskySteven V Edelman
Nov 28, 2007·Diabetes Care·Richard R Rubin, Mark Peyrot

❮ Previous
Next ❯

Citations

Jun 26, 2013·Advances in Therapy·Anthony H Barnett
Apr 28, 2012·Diabetes Technology & Therapeutics·Ronnie Aronson
Apr 12, 2014·Primary Care Diabetes·Shadi FarsaeiMostafa Qorbani
Aug 26, 2011·Expert Opinion on Drug Delivery·Birtha Hansen, Irina Matytsina
Aug 31, 2011·Current Medical Research and Opinion·Carsten M Kristensen, Søren K Lilleøre
Sep 29, 2011·Current Medical Research and Opinion·Stuart A RossJohn Ashkenas
Jun 15, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Steven P SchwendemanAnna S Schwendeman
May 18, 2012·Journal of the American Academy of Nurse Practitioners·Tom Bartol
Feb 9, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·M PeyrotP-M Schumm-Draeger
Apr 13, 2013·Diabetes, Obesity & Metabolism·R G Josse, V Woo
Apr 12, 2016·Journal of Behavioral Medicine·Chandra Y Osborn, Jeffery S Gonzalez
Jul 30, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Moawia M Al-Tabakha
Jan 1, 2015·Diabetes Technology & Therapeutics·Jodi KrallLinda Siminerio
Jan 28, 2010·Diabetes Care·Mark PeyrotLuther B Travis
Aug 24, 2013·Diabetes Care·Matthew C Riddle
Jul 2, 2016·The Journal of Pharmacy and Pharmacology·Chun Y WongCrispin R Dass
Jul 8, 2016·Advances in Therapy·Janet B McGillTricia Santos Cavaiola
Sep 7, 2016·Mayo Clinic Proceedings·Anders H FridKenneth W Strauss
Jul 28, 2016·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Sandro GentileUNKNOWN AMD-OSDI Injection Technique Study Group
Apr 28, 2012·Journal of Diabetes Science and Technology·James J Norman, Mark R Prausnitz
Feb 6, 2017·The Journal of Pharmacy and Pharmacology·Chun Y WongCrispin R Dass
Feb 13, 2018·Current Medical Research and Opinion·Mark PeyrotGérard Reach
Mar 1, 2018·Journal of Diabetes Science and Technology·Darlene M DreonMeng H Tan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.